Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | LTA4H | P09960 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL79800 | 0.76 | LTA4H (0.50) | TRPA1TSHRLTA4H | |
| SCHEMBL5885219 | 0.75 | ST14 (0.48) | TRPA1ALDH1A1TSHRLTA4HCES2 | |
| SCHEMBL29171477 | 0.74 | LTA4H (0.48) | TRPA1TSHRLTA4H | |
| SCHEMBL9651942 | 0.72 | DAO (0.35) | — | |
| SCHEMBL751190 | 0.71 | LTA4H (0.61) | TRPA1ALDH1A1TSHRLTA4HCES2 | |
| Dimethylamine SCHEMBL10731360 | 0.69 | LTA4H (0.53) | TRPA1ALDH1A1TSHRLTA4H | |
| SCHEMBL182793 | 0.68 | — | — | |
| SCHEMBL28667800 | 0.67 | HDAC1 (0.44) | TRPA1ALDH1A1TSHRCES2CES1 | |
| SCHEMBL28914769 | 0.66 | AURKA (0.36) | — | |
| Hydrochloric Acid SCHEMBL6344142 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2408756-A1 | ALPHA-(N-BENZENESULFONAMIDO)CYCLOALKYL DERIVATIVES | Bristol-Myers Squibb Company (US) | 2012-01-25 | — | — | EP | disclosed |
| WO-2010108067-A1 | ALPHA-(N-BENZENESULFONAMIDO)CYCLOALKYL DERIVATIVES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-09-23 | — | — | WO | disclosed |